201
Views
44
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease

, , , , , , , , , , & , PhD , MD show all
Pages 1078-1087 | Received 12 Jan 2007, Published online: 08 Jul 2009

References

  • McClain CJ, Kasarskis EJ, Allen JJ. Functional consequences of zinc deficiency. Prog Food Nutr Sci 1985; 19: 185–226
  • Prasad AS. Zinc and immunity. Mol Cell Biochem 1998; 188: 63–9
  • McClain CJ, Marsano L, Burk RF, Bacon B. Trace metals in liver disease. Semin Liver Dis 1991; 11: 321–37
  • Sunderman FW, Jr. Current status of zinc deficiency in the pathogenesis of neurological, dermatological and musculoskeletal disorders. Ann Clin Lab Sci 1975; 5: 132–45
  • Schölmerich J, Løhle E, Köttgen E, Gerok W. Zinc and vitamin A deficiency in liver cirrhosis. Hepato-Gastroenterology 1983; 30: 119–25
  • Prasad AS. The role of zinc in gastrointestinal and liver disease. Clin Gastroenterol 1983; 12: 713–41
  • Powell SR. The antioxidant properties of zinc. J Nutr 2000; 130: 1447S–54S
  • Bray T, Bettger WJ. The physiological role of zinc as an antioxidant. Free Rad Bio Med 1990; 8: 281–91
  • Vallee BL, Wacker WEC, Bartholomay AF, Robin ED, Vallee RL, Wacker WE. Zinc metabolism in hepatic dysfunction. I. Serum zinc concentration in Laennec's cirrhosis and their validation by sequential analysis. N Engl J Med 1956; 255: 403–8
  • Valberg LS, Flanagan PR, Ghent CN, Chamberlain MJ. Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis. Dig Dis Sci 1985; 30: 329–33
  • Goode HF, Kelleher J, Walker BE. Relation between zinc status and hepatic functional reserve in patients with liver disease. Gut 1990; 31: 694–7
  • Katayama K. Ammonia metabolism and hepatic encephalopathy. Hepatol Res 2004; 30: S71–8
  • Bode JC, Hanisch P, Henning H, Koenig W, Richter F-W, Bode C. Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. Hepatology 1988; 8: 1605–9
  • Gür G, Bayraktar Y, Özer D, Özdogan M, Kayhan B. Determination of hepatic zinc content in chronic liver disease due to hepatitis B virus. Hepato-Gastroenterology 1998; 45: 472–6
  • Ritland S, Aaseth J. Trace elements and the liver. J Hepatol 1987; 5: 118–22
  • Nandi SS, Chawla YK, Nath R, Dilawari JB. Serum and urinary zinc in fulminant hepatic failure. J Gastroenterol Hepatol 1989; 4: 209–13
  • Walker BE, Dawson JB, Kelleher J, Locowsky MS. Plasma and urinary zinc in patients with malabsorption syndromes or hepatic cirrhosis. Gut 1973; 14: 943–8
  • Riggio O, Merli M, Capocaccia L, Caschera M, Zulio A, Pinto G, et al. Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis. Hepatology 1992; 16: 785–9
  • Seltzer JL, Jeffrey JJ, Eisen AZ. Evidence for mammalian collagenase as zinc ion metalloenzymes. Biochem Biophys Acta 1977; 485: 179–87
  • Anttinen H, Puistola H, Pihlajaniemi T, Kivirikko KI. Differences between proline and lysine hydroxylations in their inhibition by zinc or by ascorbate deficiency during collagen synthesis in various cell types. Biochem Biophys Acta 1981; 674: 336–44
  • Anttinen H, Ryharnen L, Puistola U, Arranto A, Oikarinen A. Decrease in liver collagen accumulation in carbon tetrachloride-injured and normal growing rats upon administration of zinc. Gastroenterology 1984; 86: 532–9
  • Gimenez A, Pares A, Alie S, Camps J, Deulofeu R, Caballeria J, et al. Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration. J Hepatol 1994; 21: 292–8
  • Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomized controlled trial. Lancet 1984; 2: 493–4
  • Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 1996; 23: 1084–92
  • Lonard A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004; 126: 586–97
  • Olynyk JK, Reddy KR, Di Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, et al. Hepatic iron concentration as a predictor of response to interferon alpha therapy in chronic hepatitis C. Gastroenterology 1995; 108: 104–9
  • Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M, et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001; 35: 279–83
  • Larrea E, Beloqui O, Munoz-Navas MA, Civeira MP, Prieto J. Superoxide dismutase in patients with chronic hepatitis C virus infection. Free Rad Biol Med 1998; 24: 1235–41
  • Lau JYU, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501–4
  • Simmonds P, Alberti A, Alter HJ, Bomino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 1995; 22: 696–9
  • Karayalcin S, Arcasoy A, Uzunalimoglu O. Zinc plasma levels after oral zinc tolerance test in non-alcoholic cirrhosis. Dig Dis Sci 1988; 33: 1096–102
  • Giroux E, Schechter PJ, Schoun J, Sjoerdsma A. Reduced binding of added zinc in serum of patients with decompensated hepatic cirrhosis. Eur J Clin Invest 1977; 7: 71–3
  • Schechter PJ, Giroux EL, Schlienger JL, Hoenig V, Sjoerdsma A. Distribution of serum zinc between albumin and α2-macroglobulin in patients with decompensated hepatic cirrhosis. Eur J Clin Invest 1976; 6: 147–50
  • Yunice AA, King RW, Kraikitpanitch S, Haygood CC, Lindeman RD. Urinary zinc excretion following infusion of zinc sulfate, cysteine, histidine or glycine. Am J Physiol 1978; 235: 40–5
  • Takagi H, Nagamine T, Abe T, Takayama H, Sato K, Otsuka T, et al. Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. J Viral Hepat 2001; 8: 367–71
  • Haraguchi Y, Sakurai H, Hussain S, Anner BM, Hoshino H. Inhibition of HIV-1 infection by zinc group and metal compounds. Antiviral Res 1999; 43: 123–33
  • Kumel G, Schrader S, Zentgraf H, Brendel M. Therapy of banal HSV lesions: molecular mechanisms of the antiviral activity of zinc sulfate. Hautarzt 1991; 42: 439–45
  • Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003; 34: 1–10
  • Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H, Wakasa K. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J Hepatol 2001; 35: 613–8
  • Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A, et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol 1997; 50: 401–6
  • Houglum K, Venkaramani A, Lyche K, von Herbay A, Stahl W, Niederau C, et al. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-control study. Free Radic Res 1997; 27: 599–605
  • Kohen R, Yamamoto Y, Cundy KC, Ames BN. Antioxidant activity of carnosine, and anserine present in muscle and brain. Proc Natl Acad Sci 1988; 85: 3175–9
  • Klung D, Rabain J, Fridovich I. A direct determination of catalytic action of superoxide dismutase through the use of pulse radiolysis. J Biol Chem 1972; 247: 605–9
  • Saito T, Shinzawa H, Tokashi H, Wakabayashi H, Ukai K, Takahashi T, et al. Ultrastructural localization of Cu, Zn-SOD in hepatocytes of patients with various liver diseases. Histol Histopath 1989; 4: 1–6
  • Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver disease. Gastroenterology 1975; 68: 525–33
  • Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994; 89: 986–9
  • Takikawa T, Hayashi H, Nishimura N, Yano M, Isomura T, Sakamoto N. Correlation between serum levels of alanine aminotransferase and ferritin in male blood donors with antibody to hepatitis C virus. J Gastroenterol 1994; 29: 593–7
  • Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, et al. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 2001; 61: 8697–702
  • Farinati F, Cardin R, De Maria N, Libera GD, Marafin C, Lecis E, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995; 22: 44956
  • Ebadi M, Leuschen MP, el Refaey H, Hamada FM, Rojas P. The antioxidant properties of zinc and metallothionein. Neurochem Int 1996; 29: 159–66
  • Odashima M, Otaka M, Jin M, Konishi N, Sato T, Kato S, et al. Induction of a 72-kDa heat-shock protein in cultured rat gastric mucosal cells and rat gastric mucosa by zinc l-carnosine. Dig Dis Sci 2002; 47: 2709–804
  • Weismann K, Hoyer H. Serum alkaline phosphatase and serum zinc levels in the diagnosis and exclusion of zinc deficiency in man. Am J Clin Nutr 1985; 41: 1214–9
  • Kasarskis EJ, Schuna A. Serum alkaline phosphatase after treatment of zinc deficiency in humans. Am J Clin Nutr 1980; 33: 2609–12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.